| scholarly article | Q13442814 |
| P50 | author | Lucy Golden-Mason | Q47412530 |
| Hans J van der Vliet | Q57051708 | ||
| Mark Exley | Q67650208 | ||
| P2093 | author name string | S Yue | |
| R Wang | |||
| K Yanagisawa | |||
| D Schuppan | |||
| M J Koziel | |||
| H R Rosen | |||
| N Alatrakchi | |||
| P2860 | cites work | Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection | Q45732782 |
| Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis | Q45876518 | ||
| Mouse CD1 is mainly expressed on hemopoietic-derived cells. | Q46309668 | ||
| Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer | Q46482007 | ||
| Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. | Q47423311 | ||
| NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells | Q47710143 | ||
| The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice | Q50126265 | ||
| Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. | Q52012071 | ||
| Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. | Q52036459 | ||
| Loss of IFN-gamma production by invariant NK T cells in advanced cancer. | Q52934636 | ||
| CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver. | Q54586481 | ||
| Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes | Q58143640 | ||
| Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide | Q63363342 | ||
| Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d | Q71609681 | ||
| Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma | Q73119472 | ||
| CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes | Q73789797 | ||
| Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells | Q74244201 | ||
| Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis | Q77220576 | ||
| Tissue distribution, regulation and intracellular localization of murine CD1 molecules | Q77535048 | ||
| Isolation and functional use of human NKT cells | Q84977726 | ||
| Liver autoimmunity triggered by microbial activation of natural killer T cells | Q24644772 | ||
| Hepatitis C and Innate Immunity: Recent Advances | Q27487394 | ||
| Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence | Q27488844 | ||
| Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice | Q27490263 | ||
| CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver | Q28142807 | ||
| Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis | Q34090541 | ||
| Presumed guilty: natural killer T cell defects and human disease | Q34160821 | ||
| Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells | Q34542253 | ||
| Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography | Q34722878 | ||
| To be or not to be NKT: natural killer T cells in the liver. | Q35919440 | ||
| Natural killer T cell activation inhibits hepatitis B virus replication in vivo. | Q36368956 | ||
| Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells | Q36380304 | ||
| CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains | Q36404176 | ||
| Flying under the radar: the immunobiology of hepatitis C. | Q36635544 | ||
| The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection | Q36944050 | ||
| Critical contribution of liver natural killer T cells to a murine model of hepatitis | Q36979591 | ||
| Mechanisms of Disease: HCV-induced liver injury | Q36989534 | ||
| Immunobiology and pathogenesis of viral hepatitis | Q37014739 | ||
| Regulatory T cells and viral liver disease | Q37394969 | ||
| Innate-like recognition of microbes by invariant natural killer T cells | Q37398859 | ||
| The liver as a lymphoid organ | Q37419367 | ||
| Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity | Q37499317 | ||
| NKT cells: friend or foe during viral infections? | Q37615203 | ||
| Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence | Q37672414 | ||
| Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. | Q37822178 | ||
| T cell responses in hepatitis C: the good, the bad and the unconventional | Q37923263 | ||
| Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. | Q39685369 | ||
| Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. | Q40533079 | ||
| Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. | Q40753171 | ||
| A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. | Q40769888 | ||
| Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells | Q40781889 | ||
| Role of CD1d in coxsackievirus B3-induced myocarditis. | Q43834892 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 556-565 | |
| P577 | publication date | 2013-03-11 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C | |
| P478 | volume | 20 |
| Q52332737 | CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil". |
| Q38674140 | Hepatocytes as Immunological Agents |
| Q52717941 | IL13Rα2 expression identifies tissue-resident IL-22 producing PLZF+ innate T cells in the human liver. |
| Q55337327 | Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes. |
| Q90050665 | Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases |
| Q91198621 | Key features and homing properties of NK cells in the liver are shaped by activated iNKT cells |
| Q26750478 | Liver immunology and its role in inflammation and homeostasis |
| Q27025906 | Resident memory T cells in human health and disease |
| Q56378345 | The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator? |
| Q36267804 | The emerging role of resident memory T cells in protective immunity and inflammatory disease |
| Q37581353 | The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner |
| Q35750702 | Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer |
Search more.